Should Third Generation EGFR Inhibitors Be Used Before First Generation EGFR TKIs or After Progression? episode artwork

EPISODE · Dec 7, 2015 · 3 MIN

Should Third Generation EGFR Inhibitors Be Used Before First Generation EGFR TKIs or After Progression?

from GRACEcast · host cancerGRACE Meetings

Drs. Leora Horn, Ben Solomon, & Jack West consider whether third generation EGFR TKIs, so active in patients with acquired resistance, might be best used prior to development of acquired resistance.

Episode metadata supplied by the publisher feed · Published Dec 7, 2015

Embed this episode

NOW PLAYING

Should Third Generation EGFR Inhibitors Be Used Before First Generation EGFR TKIs or After Progression?

0:00 3:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 3 minutes long.

When was this GRACEcast episode published?

This episode was published on December 7, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!